NYSE · Financial Statements
AstraZeneca PLC (AZN) Financial Statements
$165.41
NYSE: AZN
Market Cap $256.53B
Overview Financials Dividend
AstraZeneca PLC most recently reported annual revenue of $58.7B, net profit of $10.3B. Revenue grew at an average annual rate of 17.2% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025
Revenue $37.4B $44.4B $45.8B $54.1B $58.7B Operating Profit $1.1B $3.8B $8.2B $10.0B $13.7B Net Profit $112.0M $3.3B $6.0B $7.0B $10.3B EPS $0.08 $2.11 $3.81 $4.50 $6.54 Op Margin 2.8% 8.5% 17.9% 18.5% 23.4%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025
Total Assets $105.4B $96.5B $101.1B $104.0B $114.1B Total Liabilities $66.1B $59.4B $62.0B $63.2B $65.4B Cash $6.3B $6.2B $5.8B $5.5B $5.7B Borrowings $30.7B $29.1B $28.6B $30.1B $29.7B
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $6.0B $9.8B $10.3B $11.9B $14.6B Investing Cash Flow $-13.3B $-5.5B $-7.8B $-12.6B $-12.7B Financing Cash Flow $-418.0M $-1.3B $-1.2B $-1.1B $-442.0M Net Cash Flow $-1.5B $-55.0M $-346.0M $-208.0M $269.0M Free Cash Flow $3.8B $7.2B $6.6B $7.3B $8.7B
Valuation & Return Ratios
Metric Value PEG Ratio 1.06 EV / EBITDA 13.95 FCF Yield 3.27% Quick Ratio 0.67 Interest Coverage 7.97 Return 1Y -0.31% Return 3Y 25.86% Return 5Y 45.06%
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .